sulfuric acid mono-(2-amino-4-methyl-phenyl ester) | 114887-34-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机硫酸及其衍生物
• 英文名称: sulfuric acid mono-(2-amino-4-methyl-phenyl ester)
• 英文别名: Schwefelsaeure-mono-(2-amino-4-methyl-phenylester)；p-Methyl-amino-phenol-sulfat；(2-amino-4-methylphenyl) hydrogen sulfate
• CAS: 114887-34-2
• 化学式: C₇H₉NO₄S
• 分子量: 203.219
• InChiKey: URAJEEIDMHNVKE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  98
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  3-甲基苯胺 在 dipotassium peroxodisulfate 作用下， 生成 sulfuric acid mono-(2-amino-4-methyl-phenyl ester)
  参考文献：
  名称：

  过硫酸盐对某些芳香胺的氧化

  摘要：

  DOI：

  10.1039/jr9540000980

文献信息

• LUBRICANT COMPOSITION, MECHANICAL ELEMENT, AND METHOD FOR PRODUCING TRIAZINE DERIVATIVES
  申请人：Negoro Masayuki

  公开号：US20080274920A1

  公开（公告）日：2008-11-06

  A lubricant composition comprising following ingredients (a) and (b) is disclosed. (a) at least one compound represented by formula (1) (b) at least one compound represented by formula (2) (R—X-) m -D   (1) (b) at least one compound represented by formula (2)
• [EN] THIOPHENE AND FURAN DERIVATIVES AS PROSTAGLANDIN AGONISTS AND USE THEREOF<br/>[FR] DERIVES DE THIOPHENE ET DE FURANNE EN TANT QU'AGONISTES DE LA PROSTAGLANDINE ET UTILISATION ASSOCIEE
  申请人：APPLIED RESEARCH SYSTEMS

  公开号：WO2004012656A2

  公开（公告）日：2004-02-12

  Substituted furan and thienyl compounds are provided, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteporosis and other destructive bone disease or disorder, renal dysfunction, an immune deficiency disorder, dry eye, ichthyosis, elevated intraocular pressure, sleep disorder, gastric ulcer, urinary dysfunction, pain, gastric motility disorders, hyperchlorhydia, inflammatory disorders and other diseases and disorders associated with the prostaglandin family of compounds.